News

AddToAny

Google+ Facebook Twitter Twitter

Precision genomics in cancer treatments

Scientists have identified genomic signatures in women developing the most common type of breast cancer that can be associated with long-term survival.

A team from NUI Galway analysed the genomes of breast cancer patients to look for associations with survival rates using advanced statistical techniques.

Early detection by national screening programmes and timely treatment for patients diagnosed with “luminal” types of breast cancer have resulted in excellent prognoses, with survival rates of over 80% within five years of treatment.

The challenge of long-term survival, however, is not as well understood and studies have shown that more than half of all recurrences for luminal breast cancers take place after this time point.

The team calculated the level of genome instability across 2000 patients, then used statistical modelling to identify distinct long-term survival outcomes. This enabled them to confirm the significantly worse prognoses for luminal A patients suffering from the most extreme levels of genome instability in their tumour biopsies.  

bit.ly/2MImKHd

Image Credit | iStock

Related Articles

Tech news: April

This month's top tech news stories

Study advances field of precision medicine

A new method of quickly mapping the genome of single cells, while also clarifying the spatial position of the cells within the body, has been revealed.

DNA in urine for cancer detection

A team of scientists has found that DNA fragments in the urine are not degraded at random or too short to provide any meaningful information.

Genetic risk factor for stroke

Researchers have identified a common genetic variant as a risk factor for stroke – especially in patients older than 65.

Top